Reference is made to the N-OTC announcement published by CondAlign AS on 18 October 2024 and on 4 November 2024 regarding that Condalign need to secure additional funding to finance the current business to facilitate continued strategic discussions.

CondAlign has initiated an application period for a convertible loan to raise a minimum of NOK 6m. The convertible loan can be converted into existing preference shares at a conversion price of NOK 8.00 per preference share. The transaction is directed at 1) existing shareholders in the Company as of 15 October 2024, as registered in the VPS on 17 October 2024, in reliance on applicable prospectus exemptions who have not expressly informed the Company that they will not subscribe for the convertible loan ("Tranche 1"); and 2) an institutional offering directed towards qualified investors in accordance with applicable prospectus exemptions ("Tranche 2"). The extended application period ended at 8 November 2024 (16:00 hours CET). 

Based on received applications the Board of Directors have allocated NOK 10.43m in the issuance of the convertible loan. This funding will secure time to support the current business and the ongoing strategic processes the company are engaged in.